ImmunoPreCept at DKTK

Engaging with the DKTK consortium and related networks is essential to maximize scientific impact and accelerate translation, particularly in areas of shared relevance such as cancer research. ImmunoPreCept contributes key expertise in understanding tissue immune regulation and health-maintaining mechanisms, identifying early cellular events in disease progression, and uncovering molecular pathways that enable deeper and more durable remission. By linking these insights with established translational and clinical networks, we can more effectively bridge discovery and application, and jointly advance precision prevention strategies across diseases.